Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2019

Feb 13, 2020

SELL
$77.66 - $99.74 $4.14 Million - $5.32 Million
-53,300 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$90.37 - $122.49 $3.21 Million - $4.35 Million
-35,500 Reduced 39.98%
53,300 $4.82 Million
Q2 2019

Aug 13, 2019

SELL
$89.51 - $118.04 $4.04 Million - $5.32 Million
-45,100 Reduced 33.68%
88,800 $10.5 Million
Q1 2019

May 08, 2019

BUY
$61.98 - $96.5 $6.91 Million - $10.8 Million
111,500 Added 497.77%
133,900 $11.6 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $986,304 - $1.45 Million
-17,600 Reduced 44.0%
22,400 $1.41 Million
Q3 2018

Nov 13, 2018

BUY
$48.29 - $80.6 $1.93 Million - $3.22 Million
40,000 New
40,000 $3.16 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.7B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.